SRINIVAS NANDURI

Employment

• National Institute of Pharmaceutical Education and Research Professor
  2013 - Present
• Albany Molecular Research Inc Director
  2012 - 2013
• Aurigene Discovery Technologies Ltd Research Director
  2008 - 2012
• Biocon Bristol-Myers Squibb Research and Development Center Chief Scientific Manager
  2008 - 2008
• Dr. Reddy's Laboratories (India) Principal Research Investigator
  1995 - 2008
• Sri Sathya Sai Institute of Higher Learning Lecturer
  1992 - 1995

Education

• Sri Sathya Sai Institute of Higher Learning PhD
  1988 - 1991
• Sri Sathya Sai Institute of Higher Learning M.Sc
  1986 - 1988
• Sri Sathya Sai Institute of Higher Learning B.Sc
  1983 - 1986

Projects & Funding

Projects & funding information is unavailable.

Publications (169)

• Efforts Toward the Development of an Efficient Synthetic Process for Levetiracetam: An Anti‐Epileptic Drug
  ChemistrySelect 2026 DOI: 10.1002/slct.74356
  +Save
• HFIP-Promoted Nenitzescu Indole Synthesis: An Application toward the Synthesis of Umifenovir
  The Journal of Organic Chemistry 2026 DOI: 10.1021/acs.joc.6c00634
  +Save
• Microwave‐Assisted Copper‐Mediated One‐Pot Sequential Synthesis of Quinolino[3,4‐b]quinoxalines
  European Journal of Organic Chemistry 2026 DOI: 10.1002/ejoc.70802
  +Save
• Synthesis and Biological Evaluation of Indole‐Benzene Sulfonamides as Carbonic Anhydrase II, IX, and XII Inhibitors
  ChemMedChem 2026 DOI: 10.1002/cmdc.70374
  +Save
• Synthesis, Biological Evaluation, and In Silico Analysis of Benzothiazolyl–Furano Thiazolidinones as Tubulin Polymerization Inhibitors
  Chemistry & Biodiversity 2026 DOI: 10.1002/cbdv.71423
  +Save
• Molecular Iodine Enabled Cascade Oxidation and Annulation for the Construction of Polycyclic 5‐aroyl‐5,6‐dihydropyrazolo[1,5‐c]Quinazolines
  Asian Journal of Organic Chemistry 2026 DOI: 10.1002/ajoc.70389
  +Save
• Exploring Coumarin‐Triazole Derivatives as Selective Inhibitors of Carbonic Anhydrase IX and XII
  ChemMedChem 2026 DOI: 10.1002/cmdc.202500959
  +Save
• Exploration of Novel Indolo[2,3-b]quinoxaline Hybrids as InhA Inhibitors: A Multi-disciplinary Approach Involving In Silico Screening, Synthesis, and Antimycobacterial Evaluation
  2026 DOI: 10.2139/ssrn.6913221
  +Save
• Exploration of Novel 4‐substituted Coumarin Derivatives as Selective Human Carbonic Anhydrase IX and XII Inhibitors: Synthesis, Biological Evaluation, and In Silico Studies
  Chemistry & Biodiversity 2025 DOI: 10.1002/cbdv.202501800
  +Save
• Sodium Dithionite-Mediated One-Pot, Tandem Reductive Cyclization of 2-(2-Nitrophenyl)quinazolin-4(3H)-one with Diverse Aldehydes and Glyoxals
  Synthesis 2025 DOI: 10.1055/a-2655-4585
  +Save